Loading…
Loading…
VEXTF does not currently pay a dividend.
Sell-side consensus EPS, revenue estimates, YoY growth, forward P/E, and per-year analyst coverage, for any covered stock.
TapClick below to see what's inside, then upgrade to unlock for this and 80,000+ other tickers.
A year-by-year projected price path from the sell-side EPS consensus, with an editable target P/E and the implied annual return from today's price.
TapClick below to see what's inside, then upgrade to unlock for VEXTF and 80,000+ other tickers.
See price against where its own fundamentals say it should trade. The shaded gap is the discount or premium, across five valuation lenses here and all seven in the Value Graph.
TapClick below to see what's inside, then upgrade to unlock for VEXTF and 80,000+ other tickers.
See exactly how VEXTF's revenue becomes profit: a Sankey that traces revenue (and its reported segments) through gross profit, operating expenses, and net profit, with the year-over-year change on every line.
The same diagram the Chart Builder draws, right on the Summary tab. Upgrade to unlock it for VEXTF and 80,000+ other tickers.
Vext Science, Inc. operates as a comprehensive enterprise within the United States' cannabis sector, encompassing agricultural technology, various services, and property management. The company is actively involved in cultivating, extracting, manufacturing, and distributing a range of THC and CBD products, including vape cartridges, concentrates, and edibles. Beyond production, it also manages retail dispensaries and handles the wholesale distribution of cannabis-derived THC and hemp-derived CBD products, marketed under its Vapen and Pure Touch Botanicals brands. Furthermore, its Vapen…
Vancouver, British Columbia--(Newsfile Corp. - October 29, 2026) - Vext Science, Inc. (CSE: VEXT) (OTCQX: VEXTF) ("Vext" or the "Company"), a U.S.-based specialty retailer operating in the regulated cannabis markets of Ohio and Arizona, today announced that the Company expects to release its financial results for the period ended September 30, 2026, before market open on Tuesday, November 3, 2026. The Company will host a conference call and webcast on the same day at 8:00 am ET to discuss the financial results for the third quarter of 2026.
Vancouver, British Columbia--(Newsfile Corp. - October 15, 2026) - Vext Science, Inc. (CSE: VEXT) (OTCQX: VEXTF) ("Vext" or the "Company"), a U.S.-based specialty retailer operating in the regulated cannabis markets of Ohio and Arizona, today announced that, in connection with the matter related to the Company's Herbal Wellness Center dispensary in Jackson, Ohio, the Ohio Division of Cannabis Control ("DCC") has authorized the removal of all sale restrictions on the Company's Vapen-branded product lines. On September 8, 2026, the DCC placed the Company's Vapen products on administrative hold based on two reported adverse health events.
Ohio Division of Cannabis Control authorizes reopening of Jackson dispensary effective September 17 Single-day obligation at maturity reduced from approximately US$5.6 million to US$2.4 million, payable in early January 2027; remaining US$3.2 million converted to fully amortizing 24-month notes Vancouver, British Columbia--(Newsfile Corp. - September 17, 2026) - Vext Science, Inc. (CSE: VEXT) (OTCQX: VEXTF) ("Vext" or the "Company"), a U.S.-based specialty retailer operating in the regulated cannabis markets of Ohio and Arizona, today announced two updates regarding its Ohio operations: (i) that the Company reopened its Herbal Wellness Center dispensary in Jackson, Ohio (the "Jackson Dispensary") today following authorization from the Ohio Division of Cannabis Control ("DCC"); and (ii) that the Company, through its wholly-owned subsidiary, Vapen Ohio, LLC ("Vapen Ohio"), and certain holders of the promissory notes (the "APP Notes") issued in connection with the Company's 2023 acquisitions of Appalachian Pharm Products, LLC and APP1803, LLC in Ohio, have agreed to a restructuring of the APP Notes which would, among other things, extend the maturity date of the APP Notes to January 15, 2029 (the "Ohio Note Restructuring"). All currency references used in this news release are in U.S. currency unless otherwise noted.
Vancouver, British Columbia--(Newsfile Corp. - September 4, 2026) - Vext Science, Inc. (CSE: VEXT) (OTCQX: VEXTF) ("Vext" or the "Company"), a U.S.-based specialty retailer operating in the regulated cannabis markets of Ohio and Arizona, today announced that it has voluntarily closed its Herbal Wellness Center dispensary located in Jackson, Ohio (the "Jackson Dispensary") at the request of the Ohio Division of Cannabis Control ("DCC") pending the DCC's investigation into two serious adverse health events that the DCC believes involve individuals who may have purchased products from the Jackson Dispensary. To date, Vext has not been provided with specific information concerning the individuals involved, the products allegedly used, the dates or circumstances of any purchases or any other information that would allow the Company to independently assess the reported medical events or determine whether there is any connection between such events and Vext products.
Vext Science Inc. (VEXTF) Q2 2026 Earnings Call Transcript